Sangamo Therapeutics (SGMOQ) Receivables - Net (2010 - 2025)
Sangamo Therapeutics (SGMOQ) reported Receivables - Net of $400,000 for Q4 2025, down 24.0% from $526,000 a year earlier and down 23.5% from the prior quarter.
Powered by 
Analysis
Sangamo Therapeutics (SGMOQ) Receivables - Net (2010 - 2025) Analysis & Trends
Dating back to Q4 2010, Sangamo Therapeutics' Receivables - Net record includes 60 quarters.
- Receivables - Net has declined for four consecutive years, with a five-year compound annual growth rate of -40.2% (FY2020 to FY2025).
- By year, Receivables - Net came in at $526,000 in FY2024 (-43.0%), $923,000 in FY2023 (-75.1%), $3.7 million in FY2022 (-38.5%) and $6.01 million in FY2021 (+15.1%).
- Five-year quarterly Receivables - Net spans a low of $366,000 in Q1 2025 and a high of $10.5 million in Q3 2024.
- Year over year, Receivables - Net has now declined in each of the last five quarters, with growth averaging 50.1% over the last eight quarters.
- The high point for year-over-year Receivables - Net in five years was Q3 2024 (growth of 814.3%); the low point was Q3 2025 (a decline of 95.0%).
- Per Business Quant data, the three quarters before Q4 2025 came in at $523,000 (Q3 2025), $372,000 (Q2 2025) and $366,000 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Sangamo Therapeutics | 28.02 Mn | -86.09 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 400,000.00 |
| Sep 30, 2025 | 523,000.00 |
| Jun 30, 2025 | 372,000.00 |
| Mar 31, 2025 | 366,000.00 |
| Dec 31, 2024 | 526,000.00 |
| Sep 30, 2024 | 10.50 Mn |
| Jun 30, 2024 | 581,000.00 |
| Mar 31, 2024 | 691,000.00 |
| Dec 31, 2023 | 923,000.00 |
| Sep 30, 2023 | 1.15 Mn |
| Jun 30, 2023 | 2.72 Mn |
| Mar 31, 2023 | 7.03 Mn |
| Dec 31, 2022 | 3.70 Mn |
| Sep 30, 2022 | 4.52 Mn |
| Jun 30, 2022 | 6.00 Mn |
| Mar 31, 2022 | 6.94 Mn |
| Dec 31, 2021 | 6.01 Mn |
| Sep 30, 2021 | 7.97 Mn |
| Jun 30, 2021 | 6.88 Mn |
| Mar 31, 2021 | 6.75 Mn |
API Access
Sangamo Therapeutics Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=SGMOQ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "SGMOQ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=SGMOQ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();